Health Biotech

What Health Biotech does

Health Biotech Limited is an India-headquartered pharmaceutical manufacturer founded in 2001 by Chairman cum Managing Director Parmjit Arora and operating two WHO-GMP certified manufacturing facilities in Baddi, Himachal Pradesh (Unit 1 at Village Sandholi and Unit 2 at Jharmajri). The company produces a broad portfolio of generic pharmaceutical formulations across injectables (dry powder and liquid), pre-filled syringes, tablets and capsules (including beta-lactam), lyophilized parenteral products, eye and ear drops, syrups and ointments—encompassing over 320 branded products and a catalog of more than 7,000 SKUs across oncology, cardiovascular, anti-infectives, antifungals, antivirals, critical care, gastrointestinal, hormonal, and respiratory therapeutic categories. Its R&D division, established in 2011, focuses on Novel Drug Delivery Systems including nanoparticle-based formulations (for anti-cancer and antibiotic drugs) and liposomal formulations (for aminoglycosides, Doxorubicin, and Amphotericin B), backed by lyophilization expertise for parenteral manufacturing.

The business generates revenue across five channels: branded pharmaceutical product sales (domestic Indian market plus exports to 57+ countries via distributor networks in Africa, CIS, Middle East, South America, and South Asia); CRAMS partnerships with leading multinational pharmaceutical companies, spanning process research and development through commercial manufacturing; loan licensing arrangements using the company's GMP-certified facilities; institutional sales to corporate hospitals, hospital chains, medical colleges, government hospitals, pharmacy chains, and direct state procurement via tenders; and direct marketing through a PCD pharma franchise model in India. International expansion is supported by MOH-level regulatory approvals in Nigeria, Iraq, Syria, Yemen, Iran, Vietnam, Cambodia, Sri Lanka, and others, and the company is actively pursuing EU GMP certification.

Health Biotech employs 51-100 people and is privately held, with leadership concentrated in the founder-MD and Director Gaurav Chawla. Customer reach spans corporate hospitals, government health systems, pharmacy chains, multinational pharma partners (via CRAMS), international distributors, and a domestic franchise network—diversifying revenue streams across institutional, retail, government, and enterprise channels. Its go-to-market leverages field sales, distributor partnerships, and regular exhibition presence at Arab Health, IPHEX, and CPHI, supported by an active online presence and earned media. Recent strategic emphasis includes EU GMP acquisition, expansion of the oncology and COVID-19 antiviral pipelines, and scaling CRAMS engagements with global pharmaceutical majors.

Name

Health Biotech

Legal name

Health Biotech Limited

Website

https://healthbiotech.in

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Short description

Health Biotech Limited is an Indian pharmaceutical manufacturer founded in 2001, operating WHO-GMP certified facilities in Baddi, producing 320-plus branded generic formulations and offering CRAMS to multinational pharma companies across 57-plus countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Contract manufacturing services
• Drug delivery systems
• Injectable formulations

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and sale of generic pharmaceutical products including injectables, tablets, capsules, syrups, and ointments. Products sold through exports to 57+ countries and domestic Indian market. Portfolio of 320+ branded products across therapeutic categories including oncology, cardiovascular, antibiotics, antifungals, and antivirals.
2. Contract Research and Manufacturing Services (CRAMS): End-to-end comprehensive CRAMS offering collaborating with leading pharmaceutical companies worldwide. Services range from process research & development to commercial manufacturing for multinational pharmaceutical companies.
3. Loan Licensing: State-of-the-art GMP certified manufacturing facilities capable of manufacturing products on loan license basis for domestic and international markets.
4. Institutional Sales: Business associations with corporate hospitals, hospital chains, medical colleges, government hospitals, pharmacy chains, and direct state procurement through tenders.
5. Direct Marketing: Region's fastest-growing pharmaceutical company providing direct marketing opportunities with wide range of products, packaging, and timely delivery.
6. In and Out Licensing: In-licensing, co-promotion, revenue-sharing, acquisition, and other partnering opportunities. Global strategic marketing partnerships for in-house products.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels5 records

Core offering

Health Biotech Limited is a global pharmaceutical manufacturer engaged in research, development, and commercial production of generic pharmaceutical products across therapeutic categories including oncology, cardiovascular, antibiotics, antifungals, antivirals, critical care, peptides, hormones, gastrointestinal, respiratory (COPD/asthma), and anesthetics. The company manufactures dosage forms including injectables, pre-filled syringes, tablets, capsules, lyophilized products, eye/ear drops, syrups, ointments, and dental cartridges. The company also offers end-to-end Contract Research and Manufacturing Services (CRAMS) to multinational pharmaceutical companies spanning process R&D to commercial manufacturing.

Product overview

Health Biotech Limited is a global pharmaceutical manufacturer based in India with a robust portfolio of over 320 branded products and more than 7000 products in its catalog. The company operates across multiple product categories including Anti-Biotic & Anti-Infective, Anti-Fungal, Anti-Retro Virals, Anesthetic, Cardiovascular, Critical Care, Gastrointestinal, Hormones, Oncology, Peptides, and Respiratory (COPD/Asthma) treatments. Key therapeutic products include RESCUEVID (Nirmatrelvir & Ritonavir), FAVIPIRAVIR, MOLNUPIRAVIR, and Remdesivir for COVID-19 treatment, along with Vasopressin injection. The company manufactures various dosage forms including Injectables (dry powder and liquid), Pre-filled Syringes, Tablets & Capsules, Lyophilized Products, Eye & Ear Drops, and Syrups & Ointments. Health Biotech offers Contract Research and Manufacturing Services (CRAMS), and its business segments include Exports, Loan Licensing, Institutional sales, Direct Marketing, and Ethical Marketing.

Differentiator

Problem solved

Functional benefit

Products and services

• RESCUEVID (Nirmatrelvir & Ritonavir tablets) Oral antiviral tablets containing Nirmatrelvir and Ritonavir used for the treatment of mild-to-moderate COVID-19 in adults and children, marketed under the RESCUEVID brand by Health Biotech Limited.
• FAVIPIRAVIR Broad-spectrum oral RdRp inhibitor antiviral medicine indicated for new and re-emerging pandemic influenza and COVID-19 treatment.
• MOLNUPIRAVIR Small molecule oral antiviral prodrug used for the treatment of mild to moderate COVID-19 in patients at risk of serious illness.
• Remdesivir COVID-19 treatment antiviral drug produced at large scale by Health Biotech Limited during the global pandemic.
• Vasopressin Injection (PFS) Life-saving Vasopressin injection in pre-filled syringe (PFS) form launched by Health Biotech Limited in the Malaysian market in 2013.
• Contract Research and Manufacturing Services (CRAMS) End-to-end Contract Research and Manufacturing Services offering covering process research and development through commercial manufacturing for multinational pharmaceutical companies. The service leverages WHO-GMP certified facilities, lyophilization expertise, and Novel Drug Delivery System capabilities.

Named customers7 records

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Multinational Pharmaceutical CompaniescoreStrategic or Co-development PartnerHealth Biotech collaborates with leading pharmaceutical companies worldwide as a fully integrated CRAMS (Contract Research and Manufacturing Services) player. They provide end-to-end, comprehensive, high-value, niche CRAMS offerings from process research & development to commercial manufacturing.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Aurobindo Pharma: Indian generic pharmaceutical manufacturer with a large injectable and oral solids portfolio, CRAMS operations, and global export presence. Direct comparable in product mix, export orientation, and CRAMS business model.
• Panacea Biotec: Indian pharma company with vaccines, injectables, and branded generics across oncology and critical care. Comparable in injectables/lyophilized product capabilities and institutional/government tender participation.
• Ipca Laboratories: Indian pharmaceutical manufacturer with strong anti-infective, antimalarial, and API capabilities plus global exports to Africa and emerging markets. Comparable on therapeutic focus and emerging-market export strategy.
• Lupin Limited: Indian-headquartered generic pharmaceutical manufacturer with strong presence in formulations (including injectables), cardiovascular and anti-infective therapeutic areas, and global exports. Comparable in dosage form diversity and export-led GTM.
• Torrent Pharmaceuticals: Mid-size Indian generic pharma manufacturer with strong cardiovascular and CNS portfolio, plus branded generics exports to semi-regulated markets. Comparable size, therapeutic mix, and geographic orientation.
• Strides Pharma Science: Indian pharma company with strong soft-gelatin capsule, oral solid, and injectable generics business, plus emerging market focus and CRAMS-like services. Comparable dosage form portfolio and semi-regulated market footprint.
• Alembic Pharmaceuticals: Indian generic pharma company focused on formulations including injectables, with regulated and semi-regulated market exports. Comparable in dosage form breadth (injectables, tablets, capsules) and API+formulations integration.

Emerging players

• Syngene International: Indian CRAMS/CDMO serving global pharma and biotech with contract manufacturing and research services. Less directly overlapping on generic product sales but highly relevant to Health Biotech's stated CRAMS growth ambition.

Broad incumbents

• Cipla Limited: Larger Indian pharma incumbent with broad generics, APIs, and complex generics portfolio including injectables and respiratory products. Overlaps with Health Biotech on anti-infective, respiratory (COPD/asthma), and institutional sales channels.
• Cadila Healthcare (Zydus): Indian pharma major with significant formulations and injectables franchise, plus global export presence. Comparable on therapeutic categories (cardiovascular, anti-infectives) and emerging markets focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/HBLHealth4All
• Facebookfacebook.com/healthbiotech
• LinkedInlinkedin.com/company/health-biotech-limited
• Instagraminstagram.com/healthbiotech

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Biotech